23 Sept 2026, 09:01
Presentations—
AVEAVECHO BIOTECHNOLOGY LIMITED
Announcement history available from 1 August 2025
Fromto
31 Aug 2026, 09:15
Company UpdateMS
27 Aug 2026, 16:53
Securities Administration—
26 Aug 2026, 08:25
Financial ResultsMS
24 Aug 2026, 09:54
Company Administration—
12 Aug 2026, 10:02
Securities Administration—
3 Aug 2026, 09:48
Company Update—
29 July 2026, 09:43
Quarterly ReportsMS
30 June 2026, 16:06
Securities Administration—
24 June 2026, 09:01
Presentations—
24 June 2026, 08:50
Company UpdateMS
23 June 2026, 09:19
Presentations—
22 June 2026, 08:31
Trading Halt / SuspensionMS
2 June 2026, 16:24
Securities Administration—
1 June 2026, 09:22
Securities Administration—
1 June 2026, 09:22
Director Interests—
27 May 2026, 09:55
Company Administration—
26 May 2026, 14:53
Meetings & Governance—
26 May 2026, 11:38
Presentations—
25 May 2026, 16:00
Meetings & Governance—
25 May 2026, 10:24
Presentations—
22 May 2026, 09:41
Periodic ReportsMS
21 May 2026, 10:16
Company UpdateMS
13 May 2026, 16:15
Director Interests—
13 May 2026, 15:53
Securities Administration—
12 May 2026, 10:54
Securities AdministrationMS
7 May 2026, 11:51
Securities Administration—
1 May 2026, 14:39
Company Administration—
29 Apr 2026, 14:13
Letters & Addresses—
29 Apr 2026, 08:33
Quarterly ReportsMS
24 Apr 2026, 09:06
Meetings & Governance—
24 Mar 2026, 09:19
Presentations—
2 Mar 2026, 09:23
Company UpdateMS
27 Feb 2026, 16:05
Company Administration—
27 Feb 2026, 16:04
Financial ResultsMS
5 Feb 2026, 09:08
Presentations—
29 Jan 2026, 13:54
Quarterly ReportsMS
18 Dec 2025, 10:32
Company UpdateMS
3 Dec 2025, 11:32
Company UpdateMS
3 Nov 2025, 11:00
Securities Administration—
3 Nov 2025, 09:57
Securities Administration—
3 Nov 2025, 09:55
Securities Administration—
31 Oct 2025, 12:55
Quarterly ReportsMS
23 Oct 2025, 08:56
Securities Administration—
23 Oct 2025, 08:54
Securities Administration—
23 Oct 2025, 08:54
Capital RaisingMS
21 Oct 2025, 08:29
Presentations—
1 Oct 2025, 08:52
Securities Administration—
28 Aug 2025, 15:16
Financial ResultsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 23 Sept 2026, 09:01 | Avecho to present at the ASX SMIDcaps Conference | Presentations | — | 03026 | |
| 31 Aug 2026, 09:15 | Avecho enters final stage of Phase III insomnia trial | Company Update | MS | 11001 | |
| 27 Aug 2026, 16:53 | Notification regarding unquoted securities - AVE | Securities Administration | — | 06021 | |
| 26 Aug 2026, 08:25 | Appendix 4D and Half-year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 24 Aug 2026, 09:54 | Avecho strengthens BD capability with senior appointment | Company Administration | — | 12008 | |
| 12 Aug 2026, 10:02 | Small Holding Share Sale Facility Completion | Securities Administration | — | 06009 | |
| 3 Aug 2026, 09:48 | Japanese patent granted for CBD capsule | Company Update | — | 11001 | |
| 29 July 2026, 09:43 | June 2026 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 30 June 2026, 16:06 | Application for quotation of securities - AVE | Securities Administration | — | 06020 | |
| 24 June 2026, 09:01 | Positive Phase III Interim Analysis Results Investor Webinar | Presentations | — | 03026 | |
| 24 June 2026, 08:50 | Positive interim results from Phase III insomnia program | Company Update | MS | 09014, 11001 | |
| 23 June 2026, 09:19 | Phase III Interim Analysis Outcome Webinar | Presentations | — | 14014 | |
| 22 June 2026, 08:31 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 2 June 2026, 16:24 | Notification regarding unquoted securities - AVE | Securities Administration | — | 06021 | |
| 1 June 2026, 09:22 | Notification of cessation of securities - AVE | Securities Administration | — | 06027 | |
| 1 June 2026, 09:22 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 27 May 2026, 09:55 | Small Holding Share Sale Facility | Company Administration | — | 06009, 12008, 16002 | |
| 26 May 2026, 14:53 | 2026 Annual General Meeting Results | Meetings & Governance | — | 08003 | |
| 26 May 2026, 11:38 | Chair's Address and CEO Presentation | Presentations | — | 03026, 15002 | |
| 25 May 2026, 16:00 | Resignation of Non-Executive Director | Meetings & Governance | — | 08005, 12001 | |
| 25 May 2026, 10:24 | Investor Webinar Presentation | Presentations | — | 03026, 14014 | |
| 22 May 2026, 09:41 | Receipt of Research & Development Tax Incentive | Periodic Reports | MS | 03014 | |
| 21 May 2026, 10:16 | Avecho completes treatment for Phase III interim analysis | Company Update | MS | 11001, 14014 | |
| 13 May 2026, 16:15 | Change of Director's Interest Notice x3 | Director Interests | — | 02009 | |
| 13 May 2026, 15:53 | Application for quotation of securities - AVE | Securities Administration | — | 06020 | |
| 12 May 2026, 10:54 | Expiry of Listed Options | Securities Administration | MS | 06009 | |
| 7 May 2026, 11:51 | Application for quotation of securities - AVE | Securities Administration | — | 06020 | |
| 1 May 2026, 14:39 | Change of Company Secretary | Company Administration | — | 12007 | |
| 29 Apr 2026, 14:13 | Letter to Optionholders - Notice of Expiry of Listed Options | Letters & Addresses | — | 16001 | |
| 29 Apr 2026, 08:33 | March 2026 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 24 Apr 2026, 09:06 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 24 Mar 2026, 09:19 | Avecho to present at NWR Virtual Healthcare Conference | Presentations | — | 14014 | |
| 2 Mar 2026, 09:23 | Avecho completes recruitment for Phase III interim analysis | Company Update | MS | 11001 | |
| 27 Feb 2026, 16:05 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 27 Feb 2026, 16:04 | Annual Report 31 December 2025 | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 5 Feb 2026, 09:08 | Avecho CEO to Present at Euroz Hartleys Healthcare Forum | Presentations | — | 03026 | |
| 29 Jan 2026, 13:54 | December 2025 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 18 Dec 2025, 10:32 | Phase III CBD Clinical Trial Recruitment Update | Company Update | MS | 11001 | |
| 3 Dec 2025, 11:32 | AVE Secures US & EU Patent Allowances for CBD Soft-Gel | Company Update | MS | 11001 | |
| 3 Nov 2025, 11:00 | Application for quotation of securities - AVE | Securities Administration | — | 06020 | |
| 3 Nov 2025, 09:57 | Application for quotation of securities - AVE | Securities Administration | — | 06020 | |
| 3 Nov 2025, 09:55 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 31 Oct 2025, 12:55 | September 2025 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 23 Oct 2025, 08:56 | Proposed issue of securities - AVE | Securities Administration | — | 06013 | |
| 23 Oct 2025, 08:54 | Proposed issue of securities - AVE | Securities Administration | — | 06013 | |
| 23 Oct 2025, 08:54 | Avecho raises $2.5m via placement | Capital Raising | MS | 06003 | |
| 21 Oct 2025, 08:29 | Presentation to Ausbiotech Invest 2025 | Presentations | — | 03026 | |
| 1 Oct 2025, 08:52 | Update - Notification regarding unquoted securities - AVE | Securities Administration | — | 06021 | |
| 28 Aug 2025, 15:16 | Appendix 4D and Half-year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 |
1–49 of 49
1 / 1